Heart Failure, Congestive Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Heart Failure, Congestive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Heart FailureHeart Failure, DiastolicCardiorenal Syndrome+5 more
Procyrion320 enrolled47 locationsNCT05677100
Recruiting

Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism

Heart Failure, Congestive
Johns Hopkins University500 enrolled1 locationNCT00181259
Recruiting

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

CardiomyopathiesArrhythmiaHeart Failure, Congestive+1 more
Johns Hopkins University1,500 enrolled4 locationsNCT00733590
Recruiting

The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure

Atrial FibrillationHeart Failure, Congestive
University Hospital Bispebjerg and Frederiksberg300 enrolled1 locationNCT06176131
Recruiting
Phase 4

Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

Heart Valve DiseasesHeart Failure, CongestiveLeft Ventricle Remodeling+2 more
Vitor Emer Egypto Rosa60 enrolled1 locationNCT07099859
Recruiting

Prediction of Heart-Failure with Machine Learning

Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure; With Decompensation+2 more
University Medical Center Goettingen32 enrolled1 locationNCT06819618
Recruiting
Not Applicable

The ROle of Compression StocKings in Heart Failure Patients

Heart Failure, CongestiveLeg EdemaVenous Insufficiency+1 more
University of Maryland, Baltimore50 enrolled1 locationNCT06350695
Recruiting

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

Atrial FibrillationVentricular DysfunctionArrhythmias, Cardiac+22 more
University Hospital of Ferrara8,400 enrolled31 locationsNCT06324682
Recruiting
Phase 4

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

Heart Failure, Congestive
Heart Center Research, LLC80 enrolled1 locationNCT06218199